Drug eluting balloons for the treatment of coronary artery disease: What can we expect?  

作　　者：Alexander Joost Volkhard Kurowski Peter W Radke 

机构地区：[1]Medical Department Ⅱ, UK S-H Campus Lübeck, University of Lübeck, D-23562 Lübeck, Germany

出　　处：《World Journal of Cardiology》2010年第9期257-261,共5页世界心脏病学杂志（英文版）（电子版）

摘　　要：Drug-eluting balloons (DEBs) represent an enhancement of the therapeutic repertoire for the interventional cardiologist. The therapeutic concept of DEBs is promising, notably on the basis of initial studies in patients with diffuse in-stent restenosis (ISR). At present, however, a number of questions regarding long-term efficacy and safety remain, specifically in indications other than diffuse ISR. The results of the evaluation of different substances, balloon systems and clinical indications will determine the long-term success of DEBs.Drug-eluting balloons (DEBs) represent an enhancement of the therapeutic repertoire for the interventional cardiologist. The therapeutic concept of DEBs is promising, notably on the basis of initial studies in patients with diffuse in-stent restenosis (ISR). At present, however, a number of questions regarding long-term efficacy and safety remain, specifically in indications other than diffuse ISR. The results of the evaluation of different substances, balloon systems and clinical indications will determine the long-term success of DEBs.

关 键 词：CORONARY artery disease CORONARY balloon ANGIOPLASTY DRUG delivery systems Vascular graft RESTENOSIS 

分 类 号：R541.4[医药卫生—心血管疾病]